Corrigendum to "Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295]
对“可切除黑色素瘤现代治疗中的辅助免疫疗法:现状及2028年展望”的更正:[ESMO Open 10 (2025) 104295]
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105492
Donia, M; Jespersen, H; Jalving, M; Lee, R; Eriksson, H; Hoeller, C; Hernberg, M; Gavrilova, I; Kandolf, L; Liszkay, G; Helgadottir, H; Zhukavets, A; Pjanova, D; Marquez-Rodas, I; Neyns, B; Westgeest, H; Pourmir, I; Sobczuk, P; Ellebaek, E; Amaral, T